RGEN Inc.
Jaime Raijman is the Chief Executive Officer at RGEN Inc., a company focused on driving innovation in genomics. Prior to this role, Jaime held various positions at Igentify, Knocki, Gene by Gene, Forge Solid, 2020 Exhibits, and Kimiko Designs, showcasing a diverse range of skills and experiences in operations, business development, design, and leadership. Jaime holds a Bachelor's degree in Biomedical/Medical Engineering from the University of Arizona and a Bachelor of Applied Science in Interior Design & Architecture from Griffith College Dublin.
This person is not in any teams
RGEN Inc.
Empowering Tomorrow, Today with Genomic Innovation RGEN Inc. is at the forefront of genomic science, bridging the gap between complex genetic data and real-world applications. With an unwavering commitment to advancing genomic technology, our multidisciplinary team offers unparalleled expertise and solutions, driving innovation for a brighter and healthier future. Our Vision: RGEN Inc. envisions a world where genomic insights are seamlessly integrated into everyday decision-making, from medical care to forensic science, ensuring a healthier and safer community for all. Our Mission: To harness the power of genomic technology and deliver actionable insights that have a transformative impact on individuals, communities, and industries. Areas of Expertise: Clinical Genomics: From pharmacogenomics to neonatal screening, we offer advanced genetic testing that provides clinicians with actionable data, optimizing patient care, and offering personalized treatment solutions. Forensic Genomic Solutions: RGEN revolutionizes forensic science through our Forensic Investigative Genetic Genealogy (FIGG) services. We assist law enforcement agencies by using genetic data to solve cold cases, identify unknown human remains, and bring closure to families. Research & Development: Staying at the cutting edge of genomic science requires constant exploration. Our dedicated R&D division collaborates with academic institutions, industry peers, and innovators to propel genomic research forward, continuously expanding the horizons of what's possible. Training & Education: Knowledge is most valuable when shared. Through specialized training courses, we empower professionals across various sectors, ensuring they're equipped to harness the benefits of genomic data in their respective fields. Collaboration & Partnership: Understanding that the realm of genomics is vast and ever-evolving, RGEN actively seeks collaboration with like-minded organizations and institutions. Our partnerships sp